Modulation of Endotoxaemia Via Curcumin Intake in Healthy Overweight Adults
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 16
- 主要终点
- Level of endotoxin in plasma.
研究概览
简要总结
Chronic diseases such as diabetes, cardiovascular diseases and cancer are a major burden on the Scottish population. Obesity and inflammation have strong links to these diseases. One of the mechanisms explaining the relationship between low-grade inflammation and excess weight is "endotoxaemia". We wish to study this phenomenon, when small components coming from our gut bacteria can pass into the bloodstream, raising the body's defences. Diet can modulate endotoxaemia. In this study, we propose to use curcumin, in a capsule form, to modulate endotoxaemia. Curcumin comes from turmeric, which is widely used as a spice. In this study, we want to test the effect of consuming curcumin extract to the composition of the gut microbiota, post-meal endotoxaemia, and inflammatory markers in blood.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Prevention
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 45 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •BMI > 25 kg/m2.
排除标准
- •having chronic inflammatory or autoimmune disease, gastrointestinal complaints or known biliary obstruction (past and present)
- •use of anti-inflammatory drugs 2 weeks before the start of the study
- •use of antibiotics during the 12 weeks preceding the trial
- •pregnancy
- •lactation
结局指标
主要结局
Level of endotoxin in plasma.
时间窗: 21 days
次要结局
未报告次要终点
研究者
Emilie Combet
Senior Lecturer
University of Glasgow
